CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Organovo Holdings, Inc. - ONVO CFD

0.57
7.55%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.53
Open 0.55
1-Year Change -68.02%
Day's Range 0.54 - 0.57
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 0.54 -0.01 -1.82% 0.55 0.55 0.53
Jul 24, 2024 0.55 -0.02 -3.51% 0.57 0.57 0.55
Jul 23, 2024 0.55 -0.02 -3.51% 0.57 0.58 0.54
Jul 22, 2024 0.56 -0.02 -3.45% 0.58 0.59 0.54
Jul 19, 2024 0.57 -0.03 -5.00% 0.60 0.60 0.56
Jul 18, 2024 0.59 0.01 1.72% 0.58 0.62 0.58
Jul 17, 2024 0.56 -0.03 -5.08% 0.59 0.59 0.56
Jul 16, 2024 0.58 -0.01 -1.69% 0.59 0.64 0.53
Jul 15, 2024 0.64 0.01 1.59% 0.63 0.65 0.62
Jul 12, 2024 0.65 -0.03 -4.41% 0.68 0.68 0.63
Jul 11, 2024 0.66 -0.03 -4.35% 0.69 0.70 0.63
Jul 10, 2024 0.69 -0.02 -2.82% 0.71 0.72 0.69
Jul 9, 2024 0.71 -0.01 -1.39% 0.72 0.72 0.70
Jul 8, 2024 0.71 -0.01 -1.39% 0.72 0.74 0.70
Jul 5, 2024 0.71 -0.02 -2.74% 0.73 0.74 0.71
Jul 3, 2024 0.74 0.01 1.37% 0.73 0.74 0.73
Jul 2, 2024 0.73 -0.01 -1.35% 0.74 0.74 0.73
Jul 1, 2024 0.73 -0.01 -1.35% 0.74 0.75 0.73
Jun 28, 2024 0.74 0.00 0.00% 0.74 0.75 0.73
Jun 27, 2024 0.74 0.00 0.00% 0.74 0.75 0.73

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Organovo Holdings, Inc. Company profile

About Organovo Holdings Inc

Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. NovoGen Bioprinters can dispense pure hydrogel formulations and also serve as important components of company's tissue prototyping and manufacturing platform. The Company also intends to use its bioprinting platform as well as 3D technologies to treat its target diseases.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Organovo Holdings Inc revenues was not reported. Net loss decreased 33% to $9.5M. Lower net loss reflects Non-cash stock-based compensation decrease of 78% to $1.2M (expense), Gain (loss) on fixed asset disposals decrease from $19K (expense) to $0K, Other income increase from $6K to $25K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$2.15 to -$1.10.

Equity composition

Common Stock $.0001 Par, 06/12 Shares auth.75M and o/s 43,772,483. Insiders 39.83%. 02/12, 10.59135-for-1 Stock split.

Industry: Biotechnology & Medical Research (NEC)

Suite 110
6275 Nancy Ridge Drive
SAN DIEGO
CALIFORNIA 92121
US

People also watch

XRP/USD

0.61 Price
+1.640% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

67,928.50 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,281.07 Price
+4.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading